Seelos Therapeutics Profit Margin

The latest profit margin for SEEL is 203.13% as of June 2024. That compares with -7657.08% in the prior-year period — up 102.7% year over year. That is above the Healthcare sector average of 15.29%. Investors often review this figure alongside Seelos Therapeutics's historical trend and sector peers before judging valuation or financial health.

Over the past year, SEEL's profit margin moved from -7657.08% to 203.13% — a 102.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Seelos Therapeutics's valuation or profitability profile.

Against Healthcare companies, SEEL currently prints 203.13% for profit margin, while the sector average sits near 15.29%. That is roughly 1228.3% above the sector mean. Large gaps often invite a closer look at Seelos Therapeutics's growth, margins, and balance sheet.

Profit Margin shows how effectively Seelos Therapeutics converts resources into returns. At 203.13%, SEEL may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -7657.08% in the prior-year period — up 102.7% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting SEEL's profit margin (203.13%), review year-over-year change from -7657.08%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.